




Searching News Database: ataluren
HSMN NewsFeed - 4 Dec 2020
PTC Announces Translarna(TM) Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
PTC Announces Translarna(TM) Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
HSMN NewsFeed - 23 Feb 2016
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
HSMN NewsFeed - 1 Jun 2009
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations